Bone non- collagenous proteins (NCPs) appear to be involved in several aspects of bone formation, as well as in the homeostatic mechanisms relative to bone remodeling. One bone NCP, osteopontin (OPN) is a sialic acid-rich phosphoprotein that is synthesized and secreted by osteoblasts and osteoclasts. A conserved RGDS sequence promotes cell attachment (osteoblasts and osteoclasts) and spreading, and possibly intracellular signaling, through interaction with a cell surface, alphav beta3 integrin. OPN may also influence the rate of mineral formation and the resultant crystal habit. The biosynthesis of OPN is up-regulated at the transcriptional level by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]; thus, OPN may manifest the actions of this hormone in its effects on bone formation and mineral homeostasis. The investigators have recently shown that, after short-term exposure of cells to 1,25(OH)2D3, there is a change in charge state of secreted OPN, including an affect on phosphorylation. The applicants have also studied the genomic regulation of OPN biosynthesis by 1,25(OH)2D3 and have found 2 vitamin D response elements (VDRE) on rat OPN gene which are involved in the increased transcription, but are regulated differently. They hyposize that the regulation of osteoblastic synthesis of OPN by 1,25(OH)2D3 involves both transcriptional and non-transcriptional mechanisms. In order to address this hypothesis, the following Specific Aims are proposed: 1) to elucidate the location and nature of the post-translational modifications (PTM) of rat bone OPN; 2) to characterize the nature and mechanism of the non-transcriptional regulation of OPN biosynthesis and PTM changes brought about by incubation of cells with 1,25(OH)2D3; and 3) to elucidate the mechanisms of genomic regulation of OPN synthesis of 1,25(OH)2D3. These studies will be performed by an interdisciplinary team of investigators. The applicants hope that the results will increase our knowledge concerning the manner by which 1,25(OH)2D3 influences bone formation and remodeling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039273-11
Application #
2517443
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1987-06-01
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Other Basic Sciences
Type
Schools of Dentistry
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Razzouk, S; Brunn, J C; Qin, C et al. (2002) Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40-7
Liu, R; Li, W; Karin, N J et al. (2000) Ribozyme ablation demonstrates that the cardiac subtype of the voltage-sensitive calcium channel is the molecular transducer of 1, 25-dihydroxyvitamin D(3)-stimulated calcium influx in osteoblastic cells. J Biol Chem 275:8711-8
French, M M; Smith, S E; Akanbi, K et al. (1999) Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 145:1103-15
Devoll, R E; Li, W; Woods, K V et al. (1999) Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity. J Oral Pathol Med 28:97-101
Thalmann, G N; Sikes, R A; Devoll, R E et al. (1999) Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5:2271-7
Farach-Carson, M C; Ridall, A L (1998) Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am J Kidney Dis 31:729-42
Safran, J B; Butler, W T; Farach-Carson, M C (1998) Modulation of osteopontin post-translational state by 1, 25-(OH)2-vitamin D3. Dependence on Ca2+ influx. J Biol Chem 273:29935-41
Snyder, W R; Hoover, J; Khoury, R et al. (1997) Effect of agents used in perforation repair on osteoblastic cells. J Endod 23:158-61
Devoll, R E; Pinero, G J; Appelbaum, E R et al. (1997) Improved immunohistochemical staining of osteopontin (OPN) in paraffin-embedded archival bone specimens following antigen retrieval: anti-human OPN antibody recognizes multiple molecular forms. Calcif Tissue Int 60:380-6
Neame, P J; Butler, W T (1996) Posttranslational modification in rat bone osteopontin. Connect Tissue Res 35:145-50

Showing the most recent 10 out of 27 publications